BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10498429)

  • 21. AEG I and II: is it one tumor entity?
    Lenglinger J; Ringhofer C; Riegler M
    Ann Surg; 2008 Jun; 247(6):1080-1; author reply 1081. PubMed ID: 18520245
    [No Abstract]   [Full Text] [Related]  

  • 22. Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.
    Wu AH; Tseng CC; Bernstein L
    Cancer; 2003 Sep; 98(5):940-8. PubMed ID: 12942560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical images in gastroenterology. Middle-third esophageal neoplasia plus gastric parasitosis].
    Reed-San Román G; Gaspar-Hernández P; Martínez-Alvarado S
    Rev Gastroenterol Mex; 2002; 67(2):107. PubMed ID: 12434803
    [No Abstract]   [Full Text] [Related]  

  • 24. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease.
    Jones MP; Sloan SS; Rabine JC; Ebert CC; Huang CF; Kahrilas PJ
    Am J Gastroenterol; 2001 Jun; 96(6):1711-7. PubMed ID: 11419819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discussion.
    J Am Coll Surg; 2015 Jul; 221(1):173-4. PubMed ID: 26095568
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction.
    Healy LA; Ryan AM; Gopinath B; Rowley S; Byrne PJ; Reynolds JV
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1284-91. PubMed ID: 17976464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.
    Siewert JR; Feith M; Stein HJ
    J Surg Oncol; 2005 Jun; 90(3):139-46; discussion 146. PubMed ID: 15895452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevalence of adenocarcinoma of the esophagus and esophagogastric junction in a 10 year period at a cancer referral center in southern Brazil].
    de Barros SG; Vidal RM; Luz LP; Ghisolfi ES; Barlem GG; Komlós F; Wolff FH; Breyer HP; Pütten AC; Dietz J; Kruel CD; Grüber AC; Prolla JC
    Arq Gastroenterol; 1999; 36(1):32-6. PubMed ID: 10511877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adenocarcinoma of the esophagogastric junction (AEG-tumor). Review of the literature].
    Pilco J; Stein J
    Rev Gastroenterol Peru; 2006; 26(2):194-9. PubMed ID: 16865166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudoachalasia.
    Barret M; Rouquette A; Massault PP; Prieux C; Brieau B; Coriat R; Chaussade S
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):99-100. PubMed ID: 28780054
    [No Abstract]   [Full Text] [Related]  

  • 31. What is adenocarcinoma of the esophagogastric junction?
    Chandrasoma P
    Am J Gastroenterol; 2008 Feb; 103(2):492-3. PubMed ID: 18289219
    [No Abstract]   [Full Text] [Related]  

  • 32. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.
    Cameron AJ; Souto EO; Smyrk TC
    Am J Gastroenterol; 2002 Jun; 97(6):1375-80. PubMed ID: 12094853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stenting and Curative Resection: In Reply to Falk.
    Martin RC
    J Am Coll Surg; 2015 Dec; 221(6):1093-4. PubMed ID: 26611800
    [No Abstract]   [Full Text] [Related]  

  • 34. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.
    Wu TT; Chirieac LR; Abraham SC; Krasinskas AM; Wang H; Rashid A; Correa AM; Hofstetter WL; Ajani JA; Swisher SG
    Am J Surg Pathol; 2007 Jan; 31(1):58-64. PubMed ID: 17197919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
    Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
    ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Scleroderma and colonic adenocarcinoma. A fortuitous association].
    Tohme A; Fayad F
    J Med Liban; 1998; 46(6):353. PubMed ID: 10349276
    [No Abstract]   [Full Text] [Related]  

  • 37. [Resectable adenocarcinoma of the oesophagogastric junction care: which perioperative treatment?].
    Créhange G; Bonnetain F; Chauffert B; Rat P; Bedenne L; Maingon P
    Cancer Radiother; 2008 Sep; 12(5):365-73. PubMed ID: 18420440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
    Zhang X; Watson DI; Jamieson GG
    Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy.
    Gianotti L; Braga M; Landoni L; Mari G; Scaltrini F; Di Castelnuovo A; Di Carlo V
    Hepatogastroenterology; 2003; 50(54):1948-52. PubMed ID: 14696439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours.
    Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
    Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.